Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Conference call in connection with Collector Bank’s year-end report 2022

Collector Bank AB (publ) will publish the year-end report for 2022 on Wednesday 8 February 2023 at 07:30 CET. A conference call will be held the same day starting at 10:00 CET, where CEO Martin Nossman and CFO Peter Olsson will present the report. The presentation will be held in Swedish and will be followed by a Q&A session.For those who wish to participate in the conference call, please dial +46 850 516 386 or +44 2031 984 884, pin code 6984892#. It is also possible to follow and listen to the presentation live on https://ir.financialhearings.com/collector-bank-q4-2022.The presentation

Nokian Tyres will publish its Financial Statement Release 2022 on February 7, 2023

Nokian Tyres plc Press Release January 25, 2023 at 11:00 a.m.  Nokian Tyres will publish its Financial Statement Release 2022 on February 7, 2023 approximately at 2:00 p.m. EET. After publication, the release will be available at www.nokiantyres.com/company/investors/.  A conference call for investors, analysts and media will be held on the publishing day at 3:00 p.m. EET. In the call, President and CEO Jukka Moisio and CFO Teemu Kangas-Kärki will present the financial results. The presentation material will be available on the company’s website at 3:00 p.m. EET at the latest.

IFS performance outpaces competitors with 5[th] consecutive year of double-digit growth

· Annual Recurring Revenue (ARR) up 57% YoY driven by bookings from new customers · Cloud revenue up 80% YoY driven by existing and new customers switching to IFS Cloud.London, January 25, 2023 – IFS , the global cloud enterprise applications company, today announced its financial results for the full year ending December 31, 2022. The company posted exceptional results with software revenue growth at 28 percent year-on-year and cloud revenue growth up 80 percent as existing customers and new customers switch to IFS Cloud. The 2022 results mark the fifth

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 24 - 25 JANUARY 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 230/22 and 233/22.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Thomas France, Investor Communications Partner, tel.: 3315 0451

Reskilling and upskilling retail industry workers: How Ingka Group plans to crack the code with EU’s Pact for Skills

The world of work is changing – faster than ever before. This is a major challenge for a company like Ingka Group (IKEA Retail) with over 170,000 co-workers across 31 countries working in the fast-paced retail sector. To meet the challenge, Ingka Group has been working to support Democratic Learning by enabling the continuous development of co-workers.Now, as part of the company’s commitment to retail skill building, Ingka Group has joined the EU’s Pact for Skills  with a focus on retail. To learn more, we recently sat down with Shannon

Read original

Ratos company Vestia signs contract for approximately SEK 700m with City of Mölndal to build new school

Vestia Construction Group (Vestia) has signed a contract with the City of Mölndal for the new construction of Västerberg School and Bifrost Preschool in Mölndal. Västerberg School will accommodate 570 pupils from the age of six to 12 (Year F–6) in 9,500-square-metre premises including a full-size sports hall and is scheduled to be completed in March 2025. Bifrost Preschool will be the largest preschool in northern Europe with 14 classes housed in 4,200 square metres. Two classes will be specifically tailored for children with functional diversity and two will be open preschool classes

Invitation to presentation in connection with EQL Pharma's quarterly report, third quarter, 2022/23

EQL Pharma AB (publ) will publish its quarterly report for the third quarter, 2022/23, on Tuesday, February 14[th], before stock markets opening. At 10.00 (CET) 14[th] February, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the quarterly report. After the presentation, there is an opportunity to ask questions for those who participate. Use the following link to access the virtual meeting: https://tinyurl.com/mth4yenpDate and time February 14[

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them   Company Announcement No. 41 -2022 OrderYOYO A/SManagers’ transactions   Copenhagen, January 25, 2023   OrderYOYO A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 (the market abuse regulation) of the below transactions related to shares in OrderYOYO A/S made by TJOYY22 ApS, closely associated to CEO Jesper Johansen, who has acquired 2,542 shares in OrderYOYO A/S at an average price of DKK 5.50 per share.

Klarna introduces Money Story: A personal overview of your spending in 2022

With clear and engaging spending insights, Money Story makes money management approachable for millions of US consumers and encourages smart financial habits for the new year New York, January 25, 2023 – Klarna , the global leader in the generational shift away from credit cards, today announced the launch of Money Story in the US Klarna App - a personal spending summary of 2022 that provides millions of consumers with useful insights into their spending habits and helps them be informed and in control of their finances. Using the animated “story” format

Read original

Nordea Economic Outlook: The Balancing Act

Global growth is weak at the moment. However, there are signs that the year 2023 could also cause positive surprises as mild weather has eased the energy crisis in Europe and China will rebound after the end of the tight covid policy. Although inflation seems to have peaked, it is still an open question how much further monetary policy tightening is needed to lower it substantially. The central banks are thus facing a delicate balancing act, with many years of ultra-accommodative monetary policy suddenly being turned upside down, says Helge Pedersen, Nordea Group Chief Economist.   This

SKF streamlines bearing analysis for Ansys users

With the new SKF Bearing App for Ansys Mechanical, design engineers have instant access to accurate stiffness data on more than 10,000 bearing designations. The app is available in the Ansys Store free of charge.Gothenburg, Sweden, 25 January 2023: Machine designers increasingly rely on earlier and more predictively accurate simulations to accelerate product development, help eliminate errors and reduce the need for physical prototypes. In many mechanical systems, such as gearboxes or electric drivetrains, bearing performance is a critical driver of overall system performance. However,

BioStock: CMO gives insight on new BioInvent collaboration

Having achieved a strong shareholder base, several important partnerships and a very successful capital raise last year, biotech company BioInvent has received yet another quality stamp. This one comes in the form of a collaboration agreement with the Leukemia & Lymphoma Society - whose blood cancer acceleration programme invests 3 MUSD in the company through a directed new issue. Going forward, BioInvent will get access to important knowledge and guidance from the patient organisation. BioStock contacted CMO Andres McAllister to get his comment.Read the article about BioInvent at biostock.

Formpipe announces preview income statement for the fourth quarter and fiscal year 2022.

Formpipe announces preview income statement and ACV/ARR for the fourth quarter and fiscal year 2022. This press release and all information herein is preliminary and unaudited.INCOME STATEMENT -SUMMARY Oct Jan -Dec -Dec mSEK 2022 2021 2022 2021 2021*License 7,0 9,9 16,6 69,3 28,4SaaS 26,3 19,4 93,8 66,1 66,1Support & 58,1 54,0 226,4 212,3 212,3MaintenanceDelivery 36,4 38,9 148,3 125,5 125,5Net revenue 127,8 122,3 485,1 473,2

Formpipe announces change of CEO.

Christian Sundin will leave as CEO of Formpipe Software AB (publ). The board has started a recruitment process and until a new CEO is appointed, Christian Sundin will continue in the role to ensure a smooth succession."We are grateful for Christian Sundin's many years of contribution as CEO of Formpipe. He has led the company successfully for 16 years, building a strong offering of competitive products to a stable customer base, and has created ever-growing recurring revenue. In addition, Christian has formed a global, competent team, which makes us equipped for the next step in the company'

Today, the first Carbonhand[®] systems are delivered to patients

Today, the new Carbonhand® is delivered to the first patients in Sweden, Norway, and Germany. Carbonhand, which was launched at the end of last year, has received high praise from patients and healthcare professionals, and now we can deliver systems that will help people with impaired hand function to be able to carry out daily activities and get back to work. The previous version of our grip enhancing glove Carbonhand has been available in Sweden, Norway and Germany for the past few years and our distributors have had the opportunity to show and trial the brand-new version of

Atrogi announces first patient treated with its ATR-258 ß\2\ adrenoceptor agonist in a phase I clinical study for the treatment of type 2 diabetes

· First-in class drug candidate for type 2 diabetes stimulates glucose uptake in skeletal muscle, lowers blood glucose levels and treats comorbidities. · This novel pharmacological approach is supported by a recent clinical publication in Nature Communications*. Solna, Sweden, January 25, 2023 – Atrogi AB (private) an early-stage Swedish pharma company today announced that the first patient has been enrolled in a Phase 1a/b study. Atrogi’s drug candidate, ATR-258 is a first in class novel ß\2\ adrenoceptor agonist with a unique mechanism of action for the treatment of type 2 diabetes

TOM Medications concludes another round of funding at over CHF 1.3 million

The latest round of funding for TOM Medications was hugely oversubscribed, at CHF 1.3 million, or over 120 percent. TOM Medications hopes the new funding will help boost its turnover, expand its community, and tap into new markets.(Wermatswil/Zurich) TOM Medications has already notched numerous successes since its launch in June 2020. Around 30 million interactions have already taken place via the app, and treatment compliance among TOM app users is 83 percent – much higher than the approximate average of 50 percent usually achieved by those with chronic health conditions. As the recent

Invitation to presentation of BioArctic’s fourth quarter report for October - December 2022 on October 20 at 9.30 a.m. CET

Stockholm, Sweden, January 25, 2023 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B)will publish the company’s fourth quarter report for October – December 2022 onFriday, February 3, 2022, at 08:00 a.m. CET.In conjunction to the report, BioArctic invites investors, analysts, and media to an audiocast with teleconference (in English) on February 3, at 09:30 CET, where Gunilla Osswald, CEO, and Jan Mattsson, CFO, will present BioArctic and comment on the fourth quarter report for October – December 2022, followed by a Q&A-session. If you wish to participate via webcast, please use the

Implantica has successfully completed ISO 13485 and MDSAP recertifications

Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, announces that after a successful recertification audit program, Implantica CE Reflux Ltd. has obtained renewed ISO 13485 Quality Management System (QMS) and Medical Device Single Audit Program (MDSAP) certificates from its notified body, BSI.The ISO 13485 recertification demonstrates that Implantica’s quality management system complies with the recognized international standard for the design, development and distribution of medical devices, and the MDSAP recertification supports a

HANZA expands its partnership with Thermia

HANZA AB (publ) expands and deepens its collaboration with Thermia AB, a world-leading supplier of heat pumps for geothermal energy. Sales to Thermia will increase by approximately SEK 35 million in the current year and are expected to continue to increase in the coming years.HANZA is expanding capacity to its existing manufacturing clusters to meet continuously growing volumes from existing and new customers. The goal is to reach a turnover of at least SEK 5 billion by 2025. A rapidly growing customer in the Group's Swedish cluster is Thermia AB, which produces, develops and markets

Keeping hope alive

There is a famous quote by American author Robert Jordan that goes something like this: “The oak fought the wind and was broken, the willow bent when it must and survived.” Indeed, the reality of being human implies several difficult truths that we should all reconcile sooner or later. There are not many sure things in this world, but what is irrefutable is that storms do not bypass anyone, and what matters is how we withstand them and what kind of wisdom they leave behind. In this game of life (and business), there is no doubt that a little resilience, patience and hope go a long way.[

Quarterly Report I 22/23

September 2022 – November 2022, Diamyd Medical AB (publ), Fiscal year 2022/2023Precision Medicine for Autoimmune Diabetes in Pivotal Phase 3Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com September 1, 2022 – November 30, 2022 · Net result: MSEK -33.0 (-37.8) · Result per share: SEK -0.4 (-0.5) · Cash flow from operating activities: MSEK -27.1 (0) · Cash and short-term investments at November 30, 2022: MSEK 130.9 (240.7). Significant events during the first

Proposal by the Nomination Committee of Alma Media’s Shareholders for the composition and remuneration of the Board of Directors of Alma Media Corporation

Alma Media Corporation                            Stock exchange release                          25 January 2023 PROPOSAL BY THE NOMINATION COMMITTEE OF ALMA MEDIA’S SHAREHOLDERS FOR THE COMPOSITION AND REMUNERATION OF THE BOARD OF DIRECTORS OF ALMA MEDIA CORPORATION The General Meeting of Shareholders of Alma Media Corporation, held on 17 March 2015, decided, by proposal of the Board of Directors of Alma Media Corporation, to set up a Nomination Committee composed of Alma Media’s Shareholders. The Nomination Committee’s duties include preparing proposals related to the election and

BNP Paribas, a leader in financing the energy transition, enters a new phase of rapid acceleration

BNP Paribas has already made a major pivot towards financing low-carbon energy production.Building on expertise developed by its Low-Carbon Transition Group, BNP Paribas is embarking on a new phase designed to rapidly accelerate the transition to a low carbon economy.This new phase is set to last until 2030, by which time BNP Paribas will have completed transitioning over 80% of its energy production financing activities to the production of low-carbon energies.BNP Paribas has already made a major pivot towards financing low-carbon energy production. · BNP Paribas’ outstanding

There are no items matching the current filter
There are no more items matching the current filter
Back to top